Dignitana AB (ST:DIGN) — Market Cap & Net Worth
Market Cap & Net Worth: Dignitana AB (DIGN)
Dignitana AB (ST:DIGN) has a market capitalization of $18.55 Million (Skr172.36 Million) as of April 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #28374 globally and #511 in its home market, demonstrating a 0.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dignitana AB's stock price Skr2.14 by its total outstanding shares 80541904 (80.54 Million).
Dignitana AB Market Cap History: 2015 to 2025
Dignitana AB's market capitalization history from 2015 to 2025. Data shows change from $184.62 Million to $18.55 Million (-17.98% CAGR).
Index Memberships
Dignitana AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$14.23 Billion | 0.13% | #114 of 281 |
Weight: Dignitana AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Dignitana AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dignitana AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
Dignitana AB's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $184.62 Million | $4.75 Million | -$16.57 Million | 38.88x | N/A |
| 2016 | $167.28 Million | $8.90 Million | -$32.27 Million | 18.79x | N/A |
| 2017 | $26.70 Million | $22.94 Million | -$42.60 Million | 1.16x | N/A |
| 2018 | $47.67 Million | $33.74 Million | -$26.02 Million | 1.41x | N/A |
| 2019 | $74.37 Million | $40.70 Million | -$38.03 Million | 1.83x | N/A |
| 2020 | $71.42 Million | $46.63 Million | -$54.93 Million | 1.53x | N/A |
| 2021 | $75.93 Million | $57.07 Million | -$43.09 Million | 1.33x | N/A |
| 2022 | $44.46 Million | $73.00 Million | -$22.41 Million | 0.61x | N/A |
| 2023 | $18.90 Million | $86.06 Million | -$17.36 Million | 0.22x | N/A |
| 2024 | $8.28 Million | $89.83 Million | -$19.18 Million | 0.09x | N/A |
Competitor Companies of DIGN by Market Capitalization
Companies near Dignitana AB in the global market cap rankings as of April 19, 2026.
Key companies related to Dignitana AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #115 globally with a market cap of $168.34 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $131.38 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #190 globally with a market cap of $110.50 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #229 globally with a market cap of $95.25 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #115 | Abbott Laboratories | NYSE:ABT | $168.34 Billion | $96.81 |
| #154 | Stryker Corporation | NYSE:SYK | $131.38 Billion | $343.32 |
| #190 | Medtronic PLC | NYSE:MDT | $110.50 Billion | $86.19 |
| #229 | Boston Scientific Corp | NYSE:BSX | $95.25 Billion | $64.23 |
Dignitana AB Historical Marketcap From 2015 to 2025
Between 2015 and today, Dignitana AB's market cap moved from $184.62 Million to $ 18.55 Million, with a yearly change of -17.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Skr18.55 Million | +124.08% |
| 2024 | Skr8.28 Million | -56.19% |
| 2023 | Skr18.90 Million | -57.50% |
| 2022 | Skr44.46 Million | -41.44% |
| 2021 | Skr75.93 Million | +6.31% |
| 2020 | Skr71.42 Million | -3.96% |
| 2019 | Skr74.37 Million | +56.00% |
| 2018 | Skr47.67 Million | +78.57% |
| 2017 | Skr26.70 Million | -84.04% |
| 2016 | Skr167.28 Million | -9.39% |
| 2015 | Skr184.62 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 18th, 2026 the market cap of Dignitana AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.55 Million USD |
| MoneyControl | $18.55 Million USD |
| MarketWatch | $18.55 Million USD |
| marketcap.company | $18.55 Million USD |
| Reuters | $18.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dignitana AB
Dignitana AB (publ), a medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from chemotherapy treatments, as well as for patients receiving chemotherapy to treat other solid tumors. The company was incorporated in 2007 is headquarter… Read more